Drug bidding database: integrating the bidding information of nearly 7000 pharmaceutical manufacturers in 3 1 province and municipality directly under the central government. Covers the drug name, standard dosage form, conversion coefficient, manufacturer, purchase price, public documents and other information. This paper summarizes the bidding information of centralized procurement platforms in various provinces, and obtains the first-hand information of analyzing the winning information of enterprises' own varieties and competitive varieties in time, which provides limited data support for the bidding work of enterprises.
National centralized drug procurement database: collect national centralized drug procurement information, summarize information from different angles according to drug name and enterprise name, and provide multi-dimensional information such as drug name, lowest unit price, specification, dosage form, reported quantity and supply province. , to help users see the results of the whole bid, bid and supply, and to provide reference for the next centralized procurement. In addition, the linkage between the database and the consistency evaluation database, combined with the enterprises that have been evaluated or are being evaluated, is an essential tool for pharmaceutical companies to make price decisions under the new situation of drug procurement.
Rong Yun national centralized drug collection database.
Consistency evaluation database: contains all the data of drugs that passed/were deemed to have passed and failed the consistency evaluation, and browses by varieties, product specifications and enterprises, analyzes the consistency evaluation information of a certain variety and enterprise, and provides data support for generic drug selection, project research and market analysis.
Consistency evaluation database
National Hospital Sales Database: Based on stratified sampling of 2,200+second-class and above hospitals (≧ 100 beds, including general hospitals 1795 beds and 473 specialist hospitals) in all provinces and cities in China, it is enlarged by professional calculation model according to the number of municipal hospitals, hospital beds, hospital types, regional diseases and local medical level. Drugs cover chemicals/biopharmaceuticals and proprietary Chinese medicines, among which chemicals/biopharmaceuticals involve 14 categories, 90 subcategories and 5000+ generic varieties; Chinese patent medicines involve 13 categories, 74 subcategories and 6000+ generic varieties. The database has flexible query mode, and can be screened according to the conditions of drugs, enterprises, ATC classification, dosage forms, routes of administration, years and so on. The analysis dimensions include annual trend, quarterly trend, enterprise sales pattern, variety sales pattern, dosage form sales pattern, specification sales pattern and drug use route sales pattern, which are presented and downloaded in the form of visual analysis, charts and raw data.
National pharmacy retail database: Based on stratified sampling of more than 5,000 retail pharmacies (entity pharmacies) in various provinces and cities, the exclusive national pharmacy retail data is generated through unique channels of national retail drug data collection, multi-level and multi-pharmacy retail data collation, standardization and statistics. On the basis of hospital sales data, it provides more sources of sales data support, which improves the accuracy and accuracy of enterprise market decision.
National sample hospital sales database: mainly from a variety of reliable data sources, such as the purchasing data of cooperative hospitals, the delivery data of cooperative pharmaceutical companies, the cooperation data of some pharmaceutical circulation enterprises, and the data procurement of the Science and Technology Development Center of Pharmaceutical Association. Through professional data cleaning and integration, the national sample hospital sales database has been formed. The data sample of this database covers about 1400+ urban public hospitals, covering 24 provinces in China, including Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Harbin, Hangzhou, Hefei, Hohhot, Jinan, Kunming, Nanjing, Shanghai, Shenzhen, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Wuhan and Xi 'an. Drugs cover chemicals/biopharmaceuticals and proprietary Chinese medicines, among which chemicals/biopharmaceuticals involve 15 categories, 90 subcategories and 4800+ generic varieties; Chinese patent medicines involve 13 categories, 70 subcategories and 4000+ generic varieties. The database has flexible query mode, and can be filtered according to drugs, enterprises, ATC classification, dosage forms, drug use routes, years, provinces/cities, etc. Through the visual analysis of annual analysis, quarterly analysis, regional/provincial/key city sales pattern, enterprise sales pattern, variety sales pattern, dosage form sales pattern, specification sales pattern, drug use route sales pattern and other different dimensions, as well as the presentation of charts and original data, we will show you the market state comprehensively.
Hospital drug sales data
The above is the database of pharmaceutical market analysis and research, in addition to the database of drug research and development, the database of rational drug use, the database of medical devices and so on.